We are live on ! Find out more
CG

Column Group Portfolio holdings

AUM $88.1M
1-Year Est. Return 148.03%
This Fund
S&P 500
This Quarter Est. Return
-45.09%
1 Year Est. Return
+148.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+23.89%
10 Year Est. Return
–
AUM
$71.3M
AUM Growth
-$89.3M
Cap. Flow
-$26.8M
Cap. Flow %
-37.65%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
SRZN icon
Surrozen
SRZN
+$2M

Top Sells

Rank Stock Value
1
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
+$28.8M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TNYA icon
1
Tenaya Therapeutics
TNYA
$163M
$29.1M 40.88%
9,400,290
– –
ORIC icon
2
Oric Pharmaceuticals
ORIC
$1.44B
$25M 35.12%
3,540,777
– –
SRZN icon
3
Surrozen
SRZN
$282M
$8.87M 12.44%
810,088
+193,548
+31% +$2M
RAPT
4
DELISTED
RAPT Therapeutics
RAPT
$8.18M 11.47%
335,078
– –
SGMT icon
5
Sagimet Biosciences
SGMT
$656M
$58.7K 0.08%
17,169
– –
RVMD icon
6
Revolution Medicines
RVMD
$43.7B
$1.78K ﹤0.01%
46
– –
NGM
7
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
– –
-18,136,735
Closed -$28.8M

Similar funds

PIS
POM Investment Strategies Raleigh, North Carolina $88.3M AUM 15.23% 1-Year Est. Return
FWM
FSR Wealth Management Elmhurst, Illinois $87.8M AUM 10.63% 1-Year Est. Return
WP
Walleye Partners Madison, Wisconsin $87.7M AUM
SHCM
Stone House Capital Management Bay Harbor Islands, Florida $88.5M AUM 149.16% 1-Year Est. Return
YIM
Yoffe Investment Management Lemoyne, Pennsylvania $87.4M AUM 30.8% 1-Year Est. Return
VPW
Variant Private Wealth Tysons, Virginia $88.9M AUM 25.07% 1-Year Est. Return
LC
Luminist Capital Grand Rapids, Michigan $89M AUM 17.66% 1-Year Est. Return
BI
Bradyco Inc Cambridge, Massachusetts $87.2M AUM 8.85% 1-Year Est. Return

Column Group's Q2 2024 Portfolio in Review

As of Q2 2024, Column Group held 7 positions worth $71.3M, down 56% from $161M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Column Group withdrew a net $26.8M in Q2 2024, closing 1 position. Its most notable exit was NGM Biopharmaceuticals, Inc. Common Stock, an estimated $28.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Column Group added an estimated $2M to Surrozen.

  • Column Group added most to Surrozen in Q2 2024, an estimated $2M increase.
  • Column Group fully exited NGM Biopharmaceuticals, Inc. Common Stock in Q2 2024, selling an estimated $28.8M.
  • Column Group's ten largest holdings make up 100% of its $71.3M portfolio in Q2 2024.
  • Column Group opened 0 new positions and closed 1 in Q2 2024.
  • Column Group's portfolio value fell 56% quarter-over-quarter to $71.3M.

Based on Column Group's 13F filing for Q2 2024, filed 15 Aug 2024.